What is Bioinformatics Software Market?
The bioinformatics software identifies putative targets using algorithms based primarily on sequence identity and thermodynamic stability between the 3'UTR and miRNA targets. Bioinformatics is a branch of science that uses technology to collect important information from the fields of bioengineering, biology, and biotechnology in order to present a logical analysis. Various software tools are used to perform the analysis, which is specially designed to create a biology analysis called bioinformatics software. Today these tools are used to create predictive models and expression analysis of various genes and phenotypes. The introduction of bioinformatics software tools has significantly reduced the technical effort, introduced accuracy, and increased the efficiency of scientific research. An increase in the need for integrated data in bioengineering, biology, and biotechnology is expected to drive the bioinformatics software market in the near future. In addition, significant demand for proteomics and genomics is expected to fuel the market globally.
The market study is being classified by Type (Cloud-based and On-premise), by Application (Genomics, Chemoinformatics and Drug Design, Proteomics, Transcriptomics and Metabolomics) and major geographies with country level break-up.
SmartGene (Switzerland), BIOVIA (United States), Affymetrix, Inc. (United States), Agilent Technologies (United States), Biobase GmbH (Germany), CLC bio (Denmark), DNASTAR, Inc. (United States), PerkinElmer, Inc. (United States), Illumina, Inc. (United States), Genedata AG (Switzerland), Genomatix Software (Germany) and Molecular Networks GmbH (Germany) are some of the key players profiled in the study.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Bioinformatics Software market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Bioinformatics Software market by Type, Application and Region.
On the basis of geography, the market of Bioinformatics Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Use in Various Genomic Applications
- Increasing Adoption Bioinformatics Tools to Decrease the Cost and Time Involved In Drug Discovery
- The Growth of the Pharmaceutical Industry and the Evolution of the Healthcare Industry
Market Trend
- Increasing In the Drug Discovery & Development Process
- The Emerging Trend of Outsourcing Bioinformatics Services and the Outstanding Technological Advancements in the Corresponding Field
Restraints
- The Annotation of Unknown Metabolic Signals
Opportunities
- The Availability of Research Funding and Government Support
- Rising Use of Bioinformatics Tools Is Evident In the Developing Regions
Challenges
- The Lack of Standardization in Bioinformatics Platforms across the Industry
Key Target Audience
Providers of Bioinformatics Software, End-Users, Potential Investors, Market Research Firms and Others